Insulin Pen Market Size Share and Industry Outlook to 2028

SKU: DMMD2033 | Last Updated On: Nov 29 2021 | No. of Pages: 180 | Available Formats

> Global Insulin Pen Market Expected to reach at a high CAGR 8.7% by 2028: DataM Intelligence

Global Insulin Pen Market is segmented By Product Type (Traditional Insulin Pen (Cartridges In Reusable Pens, Disposable Pens), Smart Insulin Pen (Bluetooth, USB) ), By Application(Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The Global "Insulin Pen Market" is expected to grow at a high CAGR 8.7% during the forecasting period (2021-2028).

Insulin pens are the devices used for the administration of insulin among diabetic patients. The ease of use and the accuracy in administration make the insulin pens usage high among the insulin users.

Source: Data M Intelligence Analysis (2019)

Market Dynamics

The major driving forces are the rising prevalence of diabetes, increasing awareness related to needlestick injuries, diabetes monitoring and therapeutics for better disease management, the surge in the adoption of connected medical devices and increasing R&D activities.

The rising prevalence of diabetes is expected to boost the market. For instance, based on Transactions of the Royal Society of Tropical Medicine and Hygiene, in 2018, 336 million people had diabetes in the middle and low-income countries. The 8th edition of the IDF Diabetes Atlas 2017 reported that the prevalence of diabetes is expected to increase to 9.9% (95% CI 7.5-12.7%) by the year 2045. Thus, the rising prevalence of diabetes is leading to increased demand for the use of insulin pens.

The increasing awareness related to needlestick injuries is expected to boost the market. For instance, needlestick injuries are the primary concern for healthcare providers worldwide. In the US, every year, approximately 8 -10 lac needlestick injuries occur to healthcare workers, and around 1000 of them get contacted with infectious diseases, and 500 to 600 die each year due to these types of injuries. Further, the World Health Organization (WHO) encourages injection safety worldwide through the Safe Injection Global Network (SIGN). It also announced that smart syringes which break after one use should be used for injections by 2020. Thus, the increasing occurrence of these types of needlestick injuries and growing awareness drive the market.

The surge in the adoption of connected devices and accessories to help people using insulin pens is expected to boost the market. For instance, Companion Medical in 2016 gained FDA clearance for the first wireless-enabled smart insulin pen called the InPen that can automatically calculate doses, track dosage history and timing, and send data reports to caregivers from a patient’s phone. Also, Dukada Trio is a 'smart cap' that works with Novo and Sanofi insulin pen types and provides a flexible grip for better handling and show time period to avoid accidental double doses. Thus, the increased adoption of connected devices and accessories is driving the market.

However, the availability of alternatives to insulin pens, limitations of insulin pens, and stringent rules for new product development are restraining the growth of the insulin pen market.  Some limitations of the insulin pens include two types of insulin that cannot be mixed in an insulin pen, leading to more injections.

Market Segmentation

The global insulin pen market can be segmented by type into traditional insulin pens and smart insulin pens.

A traditional insulin pen is segmented into cartridges in reusable pens and disposable pens. The traditional insulin pens are expected to boost the market over the forecast period, owing to the rising prevalence of diabetes and several market players that offer technically advanced products. For instance, on August 26, 2018, Julphar signed an agreement with Becton Dickinson to supply disposable insulin pens in the UAE. In 2018, Novo Nordisk launched the NovoPen 6 and NovoPen Echo Plus. They are reusable insulin pens equipped with NFC (Near Field Communication) technology, scanned near, moving the data from the pen to another device. Thus, the launch of technically advanced products by the key players is driving the market.

Smart insulin pens based on connectivity are segmented into Bluetooth and USB. The smart insulin pens segment is expected to grow at a high rate over the period of forecast. This is owing to the surge in the adoption of connected devices to tackle the rising prevalence of diabetes. For instance, on August 4, 2016, Emperra GmbH launched the world's first Bluetooth insulin pen on the market, expanding its ESYSTA product system's function. Thus, the increased number of launches of connected devices are driving the market.

Source: DataM Intelligence Analysis (2019)

The type 1 diabetes segment is expected to boost the market over the forecast period. This is owing to the rising prevalence of type 1 diabetes and the launch of new connected devices to treat them. For instance, in December 2018, the European Commission’s Insulclock project provided a solution to help type 1 diabetes manage its disease. The Insulclock system is attachable to any disposable insulin pen, turning it into a 'smart' connected pen. This can then be used with a mobile application, enabling the patients to know and record the amount automatically and the type of insulin injected, and when the insulin injection took place. Thus, the launch of new connected devices to treat type 1 diabetes is driving the market.

Distribution channels can segment the global insulin pen market into hospital pharmacies, retail pharmacies, and others. Among these, the retail pharmacies segment is expected to dominate the insulin pen market. Retail pharmacies are considered to be the most preferred channel for the patients using diabetes insulin pens. Also, the retail pharmacies are among the most go-to places opted by the patients resulting in the high share and growth of the segment in the insulin pen market over the forecast period.

Geographical Analysis

Geographically, the global insulin pen market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America was dominating the global insulin pen market in 2018. It is estimated to hold a significant market size over the forecast period (2020-2027) owing to the rising prevalence of diabetes and the development of cost-effective insulin pens by the key players.

The rising prevalence of diabetes in the region is expected to boost the market. For instance, the researchers at the American Diabetes Association estimated that between 2009 and 2034, the global diabetes population will rise from 23.7 million to 44.1 million. Also, the Centre for Disease Control and Prevention reported that in July 2017, around 29 million US adults had diabetes and is responsible for 12% of deaths in the US. Based on the National Diabetes statistics report 2017, in 30.3 million Americans, nearly 1 in 10 had diabetes. In 84.1 million American adults, approximately 1 in 3 had pre-diabetes. Thus, the rising prevalence of diabetes is increasing the demand for technically advanced products in the region.

The presence of key players following several strategies like mergers, collaborations, and product launches in the region is expected to boost the market. For instance, in March 2018, FDA approved a smart Glucose meter for (iPhone 7, 8 and iPhone X) of Dario Health corp. On June 6, 2019, DexCom Inc. and Companion Medical, Inc. had a collaboration to enable a direct exchange of CGM data of Dexcom with insulin data from InPen™ into both companies' software applications. This type of strategy is the first of its kind and paves the way for advanced diabetes decision support, an essential tool for insulin users. Thus, the presence of product approvals and the collaborations between key players are driving the market growth.

 

Source: DataM Intelligence Analysis (2019)

Competitive Landscape

The major players operating in the global insulin pen market are Novo Nordisk, Sanofi, Biocon, Julphar, Companion Medical, Owen Mumford, Ltd, Berlin-Chemie AG, Diamesco Co, Emperra GmbH E-Health Technologies, Eli Lilly and Company.

The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the insulin pen market globally. For instance,

On June 7, 2019, Companion Medical, Inc. announced new features to the InPen system, which increases its utility for InPen users and their healthcare providers. The company also launched its API, enabling the sharing of insulin data from the InPen system with other diabetes management platforms.

In March 2019, Novo Nordisk had a collaborative partnership with Abbott for the design, development, and commercialization of smart insulin pens, directly transferring the dosage logs to a digital health software application.

In March 2018, FDA approved Sanofi’s new insulin pen, Toujeo Max Solostar. The pen holds more long-acting insulin to reduce the number of injections for patients requiring long-acting insulin.

In 2018, Novo Nordisk A/S launched a Bluetooth-connected smart insulin pen. It is enabled to record the dose of insulin and timely logs.

Why Purchase the Report?

  • Visualize the composition of the global insulin pen market across each type, application, and distribution channel, highlighting the key commercial assets and players.
  • Identify commercial opportunities in the global insulin pen market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the global insulin pen market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Type mapping in excel for the key Services of all major market players.

The Global Insulin Pen Market report would provide access to approximately 70 market data tables, 58 figures, and 220 pages.

Target Audience:

  • Equipment Suppliers/ Buyers
  • Type Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Trending Topics

Insulinoma Treatment Market

Insulin Resistance Market

 

Table of Contents

  1. Insulin Pen Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Insulin Pen Market-Market Definition and Overview

  3. Insulin Pen  Market – Executive Summary

    1. Market Snippet by Product type
    2. Market Snippet by Application
    3. Market Snippet by End-user
  4. Insulin Pen Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. The rising prevalence of diabetes
        2. The surge in the adoption of connected devices
      2. Restraints
        1.  Limitations of the insulin pen
      3. Opportunity
      4. Impact Analysis
  5. Insulin Pen Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Regulatory Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
    5. Unmet Needs
  6. Insulin Pen Market - By Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      2. Market Attractiveness Index, By  Type Segment
    2. Traditional insulin pen*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
          1. Cartridges in reusable pens
          2. Disposable pens
    3. Smart insulin pen
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
        1. By connectivity
          1. Bluetooth
          2. USB
  7. Insulin Pen Market - By Application

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      2. Market Attractiveness Index, By Application Segment
    2. Type 1 Diabetes*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
    3. Type 2 Diabetes
  8. Insulin Pen Market - By Distribution channel

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      2. Market Attractiveness Index, By End-user Segment
    2. Hospital pharmacies*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
    3. Retail pharmacies
    4. Others
  9. Insulin Pen Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
  10. Insulin Pen Market Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Insulin Pen Market Company Profiles

    1. Novo Nordisk*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Sanofi
    3. Biocon
    4. Julphar
    5. Companion Medical
    6. Owen Mumford Ltd.
    7. Berlin-Chemie AG
    8. Diamesco Co
    9. Emperra GmbH E-Health Technologies
    10. Eli Lilly and Company
  12. Insulin Pen Market – Premium Insights

  13. Insulin Pen Market – Data-M

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

 LIST OF TABLES

TABLE 01 GLOBAL INSULIN PEN MARKET VALUE, BY TYPE, 2018, 2022 & 2028 ($ MILLION)

TABLE 02 GLOBAL INSULIN PEN MARKET VALUE, BY APPLICATION, 2018, 2022 & 2028 ($ MILLION)

TABLE 03 GLOBAL INSULIN PEN MARKET VALUE, BY END-USER, 2018, 2022 & 2028 ($ MILLION)

TABLE 04 GLOBAL INSULIN PEN MARKET VALUE, BY REGION, 2018, 2022 & 2028 ($ MILLION)

TABLE 05 GLOBAL INSULIN PEN MARKET VALUE, BY COUNTRY, 2018, 2022 & 2028 ($ MILLION)

TABLE 06 GLOBAL INSULIN PEN MARKET VALUE, BY TYPE, 2018, 2022 & 2028 ($ MILLION)

TABLE 07 GLOBAL INSULIN PEN MARKET VALUE, BY TYPE, 2017-2028 ($ MILLION)

TABLE 08 GLOBAL INSULIN PEN MARKET VALUE, BY APPLICATION, 2018, 2022 & 2028 ($ MILLION)

TABLE 09 GLOBAL INSULIN PEN MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION)

TABLE 10 GLOBAL INSULIN PEN MARKET VALUE, BY END-USER, 2018, 2022 & 2028 ($ MILLION)

TABLE 11 GLOBAL INSULIN PEN MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION)

TABLE 12 GLOBAL INSULIN PEN MARKET VALUE, BY REGION, 2018, 2022 & 2028 ($ MILLION)

TABLE 13 GLOBAL INSULIN PEN MARKET VALUE, BY REGION, 2017-2028 ($ MILLION)

TABLE 14 GLOBAL INSULIN PEN MARKET VALUE, BY COUNTRY, 2018, 2022 & 2028 ($ MILLION)

TABLE 15 GLOBAL INSULIN PEN MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION)

TABLE 16 NORTH AMERICA INSULIN PEN MARKET VALUE, BY TYPE, 2017-2028 ($ MILLION)

TABLE 17 NORTH AMERICA INSULIN PEN MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION)

TABLE 18 NORTH AMERICA INSULIN PEN MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION)

TABLE 19 NORTH AMERICA INSULIN PEN MARKET VALUE, BY REGION, 2017-2028 ($ MILLION)

TABLE 20 NORTH AMERICA INSULIN PEN MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION)

TABLE 21 SOUTH AMERICA INSULIN PEN MARKET VALUE, BY TYPE, 2017-2028 ($ MILLION)

TABLE 22 SOUTH AMERICA INSULIN PEN MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION)

TABLE 23 SOUTH AMERICA INSULIN PEN MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION)

TABLE 24 SOUTH AMERICA INSULIN PEN MARKET VALUE, BY REGION, 2017-2028 ($ MILLION)

TABLE 25 SOUTH AMERICA INSULIN PEN MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION)

TABLE 26 EUROPE INSULIN PEN MARKET VALUE, BY TYPE, 2017-2028 ($ MILLION)

TABLE 27 EUROPE INSULIN PEN MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION)

TABLE 28 EUROPE INSULIN PEN MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION)

TABLE 29 EUROPE INSULIN PEN MARKET VALUE, BY REGION, 2017-2028 ($ MILLION)

TABLE 30 EUROPE INSULIN PEN MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION)

TABLE 31 ASIA-PACIFIC INSULIN PEN MARKET VALUE, BY TYPE, 2017-2028 ($ MILLION)

TABLE 32 ASIA-PACIFIC INSULIN PEN MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION)

TABLE 33 ASIA-PACIFIC INSULIN PEN MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION)

TABLE 34 ASIA-PACIFIC INSULIN PEN MARKET VALUE, BY REGION, 2017-2028 ($ MILLION)

TABLE 35 ASIA-PACIFIC INSULIN PEN MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION)

TABLE 36 MIDDLE EAST & AFRICA INSULIN PEN MARKET VALUE, BY TYPE, 2017-2028 ($ MILLION)

TABLE 37 MIDDLE EAST & AFRICA INSULIN PEN MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION)

TABLE 38 MIDDLE EAST & AFRICA INSULIN PEN MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION)

TABLE 39 MIDDLE EAST & AFRICA INSULIN PEN MARKET VALUE, BY REGION, 2017-2028 ($ MILLION)

TABLE 40 MIDDLE EAST & AFRICA INSULIN PEN MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION)

TABLE 41 NOVO NORDISK: OVERVIEW

TABLE 42 NOVO NORDISK: PRODUCT PORTFOLIO

TABLE 43 NOVO NORDISK: KEY DEVELOPMENTS

TABLE 44 SANOFI: OVERVIEW

TABLE 45 SANOFI: PRODUCT PORTFOLIO

TABLE 46 SANOFI: KEY DEVELOPMENTS

TABLE 47 BIOCON: OVERVIEW

TABLE 48 BIOCON: PRODUCT PORTFOLIO

TABLE 49 BIOCON: KEY DEVELOPMENTS

TABLE 50 JULPHAR: OVERVIEW

TABLE 51 JULPHAR: PRODUCT PORTFOLIO

TABLE 52 JULPHAR: KEY DEVELOPMENTS

TABLE 53 COMPANION MEDICAL: OVERVIEW

TABLE 54 COMPANION MEDICAL: PRODUCT PORTFOLIO

TABLE 55 COMPANION MEDICAL: KEY DEVELOPMENTS

TABLE 56 OWEN MUMFORD LTD.: OVERVIEW

TABLE 57 OWEN MUMFORD LTD.: PRODUCT PORTFOLIO

TABLE 58 OWEN MUMFORD LTD.: KEY DEVELOPMENTS

TABLE 59 BERLIN-CHEMIE AG: OVERVIEW

TABLE 60 BERLIN-CHEMIE AG: PRODUCT PORTFOLIO

TABLE 61 BERLIN-CHEMIE AG: KEY DEVELOPMENTS

TABLE 62 DIAMESCO CO: OVERVIEW

TABLE 63 DIAMESCO CO: PRODUCT PORTFOLIO

TABLE 64 DIAMESCO CO: KEY DEVELOPMENTS

TABLE 65 EMPERRA GMBH E-HEALTH TECHNOLOGIES: OVERVIEW

TABLE 66 EMPERRA GMBH E-HEALTH TECHNOLOGIES: PRODUCT PORTFOLIO

TABLE 67 EMPERRA GMBH E-HEALTH TECHNOLOGIES: KEY DEVELOPMENTS

TABLE 68 ELI LILLY AND COMPANY: OVERVIEW

TABLE 69 ELI LILLY AND COMPANY: PRODUCT PORTFOLIO

TABLE 70 ELI LILLY AND COMPANY: KEY DEVELOPMENTS

 

LIST OF FIGURES

FIGURE 01 GLOBAL INSULIN PEN MARKET SHARE, BY TYPE, 2018 & 2028 (%)

FIGURE 02 GLOBAL INSULIN PEN MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)

FIGURE 03 GLOBAL INSULIN PEN MARKET SHARE, BY END-USER, 2018 & 2028 (%)

FIGURE 04 GLOBAL INSULIN PEN MARKET SHARE, BY REGION, 2018 & 2028 (%)

FIGURE 05 GLOBAL INSULIN PEN MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)

FIGURE 06 GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 07 GLOBAL INSULIN PEN MARKET Y-O-Y GROWTH, BY TYPE, 2018-2028 (%)

FIGURE 08 TRADITIONAL INSULIN PEN: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 09 SMART INSULIN PEN: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 10 GLOBAL INSULIN PEN MARKET Y-O-Y GROWTH, BY APPLICATION, 2018-2028 (%)

FIGURE 11 TYPE 1 DIABETES: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 12 TYPE 2 DIABETES: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 13 GLOBAL INSULIN PEN MARKET Y-O-Y GROWTH, BY END-USER, 2018-2028 (%)

FIGURE 14 HOSPITAL PHARMACIES: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 15 RETAIL PHARMACIES: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 16 OTHERS: GLOBAL INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 17 GLOBAL INSULIN PEN MARKET Y-O-Y GROWTH, BY REGION, 2018-2028 (%)

FIGURE 18 GLOBAL INSULIN PEN MARKET Y-O-Y GROWTH, BY COUNTRY, 2018-2028 (%)

FIGURE 19 NORTH AMERICA INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 20 NORTH AMERICA INSULIN PEN MARKET SHARE, BY TYPE, 2018 & 2028 (%)

FIGURE 21 NORTH AMERICA INSULIN PEN MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)

FIGURE 22 NORTH AMERICA INSULIN PEN MARKET SHARE, BY END-USER, 2018 & 2028 (%)

FIGURE 23 NORTH AMERICA INSULIN PEN MARKET SHARE, BY REGION, 2018 & 2028 (%)

FIGURE 24 NORTH AMERICA INSULIN PEN MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)

FIGURE 25 SOUTH AMERICA INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 26 SOUTH AMERICA INSULIN PEN MARKET SHARE, BY TYPE, 2018 & 2028 (%)

FIGURE 27 SOUTH AMERICA INSULIN PEN MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)

FIGURE 28 SOUTH AMERICA INSULIN PEN MARKET SHARE, BY END-USER, 2018 & 2028 (%)

FIGURE 29 SOUTH AMERICA INSULIN PEN MARKET SHARE, BY REGION, 2018 & 2028 (%)

FIGURE 30 SOUTH AMERICA INSULIN PEN MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)

FIGURE 31 EUROPE INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 32 EUROPE INSULIN PEN MARKET SHARE, BY TYPE, 2018 & 2028 (%)

FIGURE 33 EUROPE INSULIN PEN MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)

FIGURE 34 EUROPE INSULIN PEN MARKET SHARE, BY END-USER, 2018 & 2028 (%)

FIGURE 35 EUROPE INSULIN PEN MARKET SHARE, BY REGION, 2018 & 2028 (%)

FIGURE 36 EUROPE INSULIN PEN MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)

FIGURE 37 ASIA-PACIFIC INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 38 ASIA-PACIFIC INSULIN PEN MARKET SHARE, BY TYPE, 2018 & 2028 (%)

FIGURE 39 ASIA-PACIFIC INSULIN PEN MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)

FIGURE 40 ASIA-PACIFIC INSULIN PEN MARKET SHARE, BY END-USER, 2018 & 2028 (%)

FIGURE 41 ASIA-PACIFIC INSULIN PEN MARKET SHARE, BY REGION, 2018 & 2028 (%)

FIGURE 42 ASIA-PACIFIC INSULIN PEN MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)

FIGURE 43 MIDDLE EAST & AFRICA INSULIN PEN MARKET VALUE, 2017-2028 ($ MILLION)

FIGURE 44 MIDDLE EAST & AFRICA INSULIN PEN MARKET SHARE, BY TYPE, 2018 & 2028 (%)

FIGURE 45 MIDDLE EAST & AFRICA INSULIN PEN MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)

FIGURE 46 MIDDLE EAST & AFRICA INSULIN PEN MARKET SHARE, BY END-USER, 2018 & 2028 (%)

FIGURE 47 MIDDLE EAST & AFRICA INSULIN PEN MARKET SHARE, BY REGION, 2018 & 2028 (%)

FIGURE 48 MIDDLE EAST & AFRICA INSULIN PEN MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)

FIGURE 49 NOVO NORDISK: FINANCIALS

FIGURE 50 SANOFI: FINANCIALS

FIGURE 51 BIOCON: FINANCIALS

FIGURE 52 JULPHAR: FINANCIALS

FIGURE 53 COMPANION MEDICAL: FINANCIALS

FIGURE 54 OWEN MUMFORD LTD.: FINANCIALS

FIGURE 55 BERLIN-CHEMIE AG: FINANCIALS

FIGURE 56 DIAMESCO CO: FINANCIALS

FIGURE 57 EMPERRA GMBH E-HEALTH TECHNOLOGIES: FINANCIALS

FIGURE 58 ELI LILLY AND COMPANY: FINANCIALS

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest